Evidence map›Paper›PMID 26045294›Full record

Trial reportHaematologica2015

BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures.

Judith M Boer, João R M Marchante, William E Evans, Martin A Horstmann, Gabriele Escherich, Rob Pieters, Monique L Den Boer

Open access · goldAbstract readClinical TrialComparative StudyLetter
In one paragraph

Trial report in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Frontiers in cell and developmental biology · 2022
    Review
  14. Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?Best practice & research. Clinical haematology · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Judith M BoerDepartment of Pediatric Oncology/Hematology, Erasmus MC -Sophia Children's Hospital, Rotterdam, The Netherlands.
João R M MarchanteDepartment of Pediatric Oncology/Hematology, Erasmus MC -Sophia Children's Hospital, Rotterdam, The Netherlands.
William E EvansChildren's Oncology Group, Monrovia, CA, USA Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Martin A HorstmannCOALL Study Group, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Gabriele EscherichCOALL Study Group, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rob PietersDepartment of Pediatric Oncology/Hematology, Erasmus MC -Sophia Children's Hospital, Rotterdam, The Netherlands Dutch Childhood Oncology Group, The Hague, The Netherlands Princes Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Monique L Den BoerDepartment of Pediatric Oncology/Hematology, Erasmus MC -Sophia Children's Hospital, Rotterdam, The Netherlands Dutch Childhood Oncology Group, The Hague, The Netherlands m.l.denboer@erasmusmc.nl.
Erasmus MC - Sophia Children’s Hospital · NLStichting Kinderoncologie Nederland · NLChildren's Oncology Group · USUniversität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)R37CA036401 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI EVANS, WILLIAM E · 1987 to 2014
$9.7M
NCI NIH HHS CA21765NCI NIH HHS P30 CA021765NCI NIH HHS R37 CA036401NCI NIH HHS R37-CA36401
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fusion Proteins, bcr-ablPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentCase-Control StudiesChildDisease-Free SurvivalFemaleHumansMaleSurvival RateBCR-ABL1 fusion protein, humanFusion Proteins, bcr-ablBCR-ABL1-like ALLCRLF2dic(9;20)iAMP21IKZF1JAK2kinaseprognosistranslocation

Identifiers

PMID26045294
PMCPMC4800707
OpenAlexW2291203819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.